PuSH - Publikationsserver des Helmholtz Zentrums München

Lopez del Amo, J.M. ; Fink, U.* ; Dasari, M. ; Grelle, G.* ; Wanker, E.E.* ; Bieschke, J.* ; Reif, B.

Structural properties of EGCG-induced, nontoxic Alzheimer's disease Aβ oligomers.

J. Mol. Biol. 421, 517-524 (2012)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
The green tea compound epigallocatechin-3-gallate (EGCG) inhibits Alzheimer's disease beta-amyloid peptide (A beta) neurotoxicity. Solution-state NMR allows probing initial EGCG-A beta interactions. We show that EGCG-induced A beta oligomers adopt a well-defined structure and are amenable for magic angle spinning solid-state NMR investigations. We find that EGCG interferes with the aromatic hydrophobic core of A beta. The C-terminal part of the A beta peptide (residues 22-39) adopts a beta-sheet conformation, whereas the N-terminus (residues 1-20) is unstructured. The characteristic salt bridge involving residues D23 and K28 is present in the structure of these oligomeric A beta aggregates as well. The structural analysis of small-molecule-induced amyloid aggregates will open new perspectives for Alzheimer's disease drug development.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
4.001
1.187
116
141
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Alzheimer's Disease ; Beta-amyloid Peptide ; Magic Angle Spinning (mas) Solid-state Nmr Spectroscopy ; Drug Development ; Neurotoxicity; Solid-State Nmr; Amyloid Fibrils; Green Tea; Experimental Constraints; Peptide; Toxicity; Inhibitors; (-)-Epigallocatechin-3-Gallate; Neurotoxicity; Spectroscopy
Sprache englisch
Veröffentlichungsjahr 2012
HGF-Berichtsjahr 2012
ISSN (print) / ISBN 0022-2836
e-ISSN 1089-8638
Quellenangaben Band: 421, Heft: 4-5, Seiten: 517-524 Artikelnummer: , Supplement: ,
Verlag Elsevier
Begutachtungsstatus Peer reviewed
POF Topic(s) 30203 - Molecular Targets and Therapies
30505 - New Technologies for Biomedical Discoveries
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-503090-001
G-503000-004
PubMed ID 22300765
Scopus ID 84864281808
Erfassungsdatum 2012-09-27